
Boston Scientific Corp. Stock Underperforms Thursday When Compared To Competitors

I'm PortAI, I can summarize articles.
Boston Scientific Corp.'s stock fell 1.02% to $91.75 on Thursday, underperforming compared to competitors like Abbott Laboratories, which rose 0.60%. The stock is 16.21% below its 52-week high. Trading volume was higher than average, at 11.1 million shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

